Adverse reactions to chlorpromazine in psychiatric patients.

In 470 consecutively monitored psychiatric inpatients who received chlorpromazine, adverse reactions attributed to the drug were reported in 150 (31.9%); and in three, the reaction was considered life-threatening (0.6%). Reactions were more frequent with higher daily doses and the intramuscular route was associated with earlier onset of a reaction.